On December 21, 2021 Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, reported that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 5:15 pm ET (Press release, Aligos Therapeutics, DEC 21, 2021, View Source/news-releases/news-release-details/aligos-therapeutics-present-40th-annual-jp-morgan-healthcare" target="_blank" title="View Source/news-releases/news-release-details/aligos-therapeutics-present-40th-annual-jp-morgan-healthcare" rel="nofollow">View Source [SID1234597519]). Both the presentation and the Q&A session will be held virtually.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An audio webcast of the presentation will be available through the Aligos investor section of the website. View Source

The Aligos management team will also participate in investor 1×1 meetings during the conference. Please contact your J.P. Morgan Healthcare representative to schedule virtual one-on-one meetings with Aligos during the conference. For more information about the 40th Annual J.P. Morgan Healthcare Conference, please refer to the Conference Website.